Document Type
Journal Article
Publication Date
9-1-2017
Journal
Hematology/Oncology and Stem Cell Therapy
Volume
10
Issue
3
DOI
10.1016/j.hemonc.2017.02.003
Keywords
Humans; Lymphoma, Mantle-Cell; Precision Medicine; Prognosis
Abstract
Mantle cell lymphoma is a clinically heterogeneous disease occurring within a heterogeneous patient population, highlighting a need for personalized therapy to ensure optimal outcomes. It is therefore critical to understand the benefits and risks associated with both intensive and deintensified approaches. In the following review we provide a therapeutic roadmap to strategically guide treatment for newly diagnosed and relapsed/refractory patients highlighting pivotal and recently published results involving known and novel therapies.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
APA Citation
Sandoval-Sus, J., Sotomayor, E., & Shah, B. (2017). Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine.. Hematology/Oncology and Stem Cell Therapy, 10 (3). http://dx.doi.org/10.1016/j.hemonc.2017.02.003
Peer Reviewed
1
Open Access
1
Comments
Reproduced with permission of Elsevier B.V. Ltd. or its licensors or contributors.
Mantle Cell Lymphoma: Contemporary Diagnostic and Treatment Perspectives in the Age of Personalized Medicine